Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the long-term safety and effectiveness of growth hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth Hormone Deficiency), TS (Turner Syndrome...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
LG Chem
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more
NCT07333521 · Isolated Non-acquired Growth Hormone Deficiency
NCT05775523 · Growth Hormone Deficiency
NCT00227253 · Chromosome Aberrations, Growth Hormone Deficiency, and more
Seoul National University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions